✦ LIBER ✦

Efficacy of combination multidrug chemotherapy (mitomycin, ifosfamide and cisplatin) and radiotherapy for treatment of brain metastases in non small cell lung cancer

Book ID: 123166636
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 148 KB
Volume: 12
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(95)98930-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concomitant brain radiotherapy and vinor

Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancer

✍ QUANTIN, X; KHIAL, F; REMESAUMON, M; MICHEL, F; PUJOL, J 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Randomized phase II trial comparing two

Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer: Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Ifosfamide, cisplatin, vinblastine combi

Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer

✍ Hiroshi Saito; Kaoru Shimokata; Masashi Yamamoto; Hideo Saka; Shuzo Sakai; Hidea 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 214 KB

Ifosfamide, cisplatin, vinblastine combi

Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 321 KB

Mitomycin C, vinblastine and cisplatin c

Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer

✍ Fumio Nomura; Kaoru Shimokata; Hiroshi Saito; Shuzo Sakai; Atsushi Watanabe; Hid 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 277 KB

Combination chemotherapy with mitomycin-

Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit